other central European countries (4) . Vancomycin resistance was not noted during the study period; however, 4 vancomycin-intermediate MRSA isolates were noted in 2004, 2005, and 2006 , in concordance with the sporadic occurrence of MRSA with intermediate susceptibility to glycopeptides recently reported for other European countries (3) .
The percentage of patients with vancomycin-resistant E. faecium and E. faecalis was low (median 0.4%) (Figure, panel A) . In total, 10 E. faecium and 4 E. faecalis isolates with resistance to vancomycin were reported; most were from hospitalized patients. As in most European countries, human infections due to glycopeptideresistant enterococci remain rare in Austria, although a high proportion of glycopeptide-resistant E. faecium was reported recently from animals used in food production (5 ESBLs among Klebsiella spp. ranged between 0.6% and 1.6%. In 2005 and 2006, the rate of ESBL-producing Klebsiella spp. increased to 3.8% (44 isolates) and 4.5% (55 isolates), respectively, and originated mainly from intensive care units (Figure, panel B) . In 2005, a single Klebsiella pneumoniae isolate showed reduced susceptibility to imipenem (MIC 2 μg/mL) and to meropenem (MIC 4 μg/mL) and resistance to ertapenem (MIC >16 μg/mL). Nevertheless, production of ESBL by Enterobacteriaceae organisms is still rare in southeast Austria compared with other European countries (6). However, a dramatic increase of ESBL-producing E. coli and Klebsiella spp. has been observed during recent years.
The increase of ESBL-producing E. coli isolates in outpatients with urinary tract infections leads to serious treatment problems. Results from a recent study indicate that the increase of ESBL-producers in southeast Austria is caused mainly by the emergence of CTX-M-type ESBLs, which are increasingly being isolated from outpatients (7). The K. pneumoniae isolate found in 2005 represents the fi rst ESBL-producing isolate not susceptible to carbapenems reported from Austria. Development of resistance to carbapenems in Enterobacteriaceae organisms has been reported increasingly, which substantially limits treatment options for persons with multidrug-resistant gram-negative infections (8) .
Our data show insignifi cant changes in prevalence of MRSA and vancomycin-resistant enterococci in southeast Austria during the past decade but an alarming increase of multidrug-resistant ESBL-producing E. coli and Klebsiella spp. isolates in recent years. Detection of an ESBLproducing K. pneumoniae isolate with reduced susceptibility to carbapenems shows that pathogens with new mechanisms of resistance are emerging in this region.
Osteomyelitis of Parietal Bone in Melioidosis
To the Editor: In Europe and the United States, melioidosis is a rare disease, with no cases reported thus far from Slovenia. However, it is a relatively common disease in certain areas of Southeast Asia and northern Australia. Potentially fatal, this disease is caused by the gram-negative bacillus Burkholderia pseudomallei, an environmental organism found in the soil and water of disease-endemic areas. Human infections are mostly acquired through percutaneous inoculation during contact with contaminated water and soil, although inhalation is also a recognized route of acquisition (1) . Heavy monsoon rain is associated with severe disease course (2). Melioidosis was reported in some persons injured in the Tsunami in 2004 (3). The disease has a wide spectrum of signs and symptoms (4) . Osteomyelitis is a rare manifestation. It occurs in <5% of cases and is a clinical challenge to diagnose and treat (1, 4, 5) .
We describe a case of melioidosis in a previously healthy, 40-year-old Slovenian man. The patient had been working as a basketball trainer in Jordan for the previous 12 months and was traveling to Brunei in mid-summer 2006, 14 days before the illness started. While visiting Brunei, he sustained a minor head trauma when he hit his head on a night table at the hotel. Ten days later, high-grade fever up to 40°C developed, without any other signs or symptoms of disease. After returning to Jordan, the patient was admitted to a local hospital and received different antimicrobial agents without any improvement of his medical condition. After 6 weeks of unsuccessful treatment, he decided to continue medical treatment in Slovenia.
On admission to our hospital, he reported headache and persistent high fever of 6 weeks' duration. Physi-
